Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (PEPST) and exciton-plasmon enhanced phototherapy (EPEP)
US8951561B2 · kind B2 · utility
13Cited by
39References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 20, 2009 |
| Grant date | Feb 10, 2015 |
| Priority date | — |
| Expiry date | Dec 19, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/57
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of plasmonics enhanced photospectral therapy (PEPST) and exiton-plasmon enhanced phototherapy (EPEP) in the treatment of various cell proliferation disorders, and the PEPST and EPEP agents and probes used therein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.